Drug Trial Radar · NCT01703533
A Safety Study of NNZ-2566 in Patients With Rett Syndrome
Last checked: Nov 19, 2026Latest source record: Feb 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
67
Actual
Start
Mar 2013
Primary completion
Sep 2014
Study completion Sep 2014
Sponsor
- Lead sponsor
- Neuren Pharmaceuticals LimitedIndustry
- Sponsor type
- Industry
- Collaborators
- Baylor College of Medicine; International Rett Syndrome Foundation
- First posted
- Oct 10, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 16 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether NNZ-2566 is safe and well tolerated in the treatment of Rett Syndrome in adolescent and adult females.
Conditions
- Rett Syndrome
Interventions
NNZ-2566Drug
Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566) supplied as a lyophilized powder (2g in 50mL vials) for reconstitution with strawberry flavored solution 0.5% v/v in Water for Injection.
PlaceboDrug
Strawberry flavored solution and Water for Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: Through to Day 40
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota
Baylor School of Medicine
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.